Current position
- Chief, Division of Uro-oncology, Department of Urology, Buddhist Tzu Chi General Hospital
- Assistant Professor, Department of Urology, School of Medicine, Tzu Chi University
- Director, Taiwanese Continence Society
- Member, Committee of Robotic and Laparoscopic surgery, Taiwan Urological Association
Personal
- Chief, Division of Reconstructive Surgery and Endourology, Department of Urology, Buddhist Tzu Chi General Hospital
- Lecturer, Department of Urology, School of Medicine, Tzu Chi University
- Member, Committee of Endourology, Taiwan Urological Association
- Member, Committee of VUDS and Female Urology, Taiwan Urological Association
- Member, Committee of Interstitial Cystitis, Taiwan Urological Association
- Member, Committee of Neurogenic Voiding Dysfunction, Taiwan Urological Association
Education
- School of Medicine, Tzu Chi University (2001/09 ~ 2008/06)
Background
- Residency in the Department of Urology, Buddhist Tzu Chi General Hospital
- Fellowship in the Department of Urology, Buddhist Tzu Chi General Hospital
- Attending physician of the Department of Urology, Buddhist Tzu Chi General Hospital
- Chief, Division of Reconstructive Surgery and Endourology, Department of Urology, Buddhist Tzu Chi General Hospital
- 2014 Asan Medical Center da Vinci System Training
- 2016 EAU-TUA fellowship exchange programPublications
【1】Jiang YH, Ke QS, Kuo HC: Clinical symptoms and videourodynmic findings of detrusor overactivity in women. Urol Sci 2011;22:116-9.
【2】Lee KF, Hsu CS, Kuo PL, Chen JL, Jiang YH, Liu IY: The identification of a spontaneous 47, XX, +21/46, XY chimeric fetus with male genitalia. BMC Med Genet 2012;13:85. (SCI)
【3】Jiang YH, Kuo HC, Hsu YH: Renal endometriosis mimicking an angiomyolipoma: A case report. Urol Sci 2013;24:24-6.
【4】Jiang YH, Wang CC, Chuang FC, Ke QS, Kuo HC: Positioning of a suburethral sling at the bladder neck is associated with a higher recurrence rate of stress urinary incontinence. J Ultrasound Med 2013;32:239-45. (SCI)
【5】Chou YC, Jiang YH, Harnod T, Kuo HC: Characteristics of neurogenic voiding dysfunction in cerebellar stroke: A cross-sectional, retrospective video urodynamic study. Cerebellum 2013;12:601-6. (SCI)
【6】Jiang YH*, Lin VC*, Liao CH, Kuo HC: International prostatic symptom score - voiding/storage subscore ratio in association with total prostatic volume and maximum flow rate is diagnostic of bladder outlet-related lower urinary tract dysfunction in men with lower urinary tract symptoms. PLoS One 2013;8:e59176. (SCI) (*: equal contribution)
【7】Lee CL, Jiang YH, Kuo HC: Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls. BJU Int 2013;112:1156-62. (SCI)
【8】Liu HT, Jiang YH, Kuo HC: Increased serum adipokines implicate chronic inflammation in the pathogenesis of overactive bladder syndrome refractory to antimuscarinic therapy. PLoS One 2013;8:e76706. (SCI)
【9】Jiang YH, Peng CH, Liu HT, Kuo HC: Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome. PLoS One 2013;8:e76779. (SCI)
【10】Jiang YH, Liu HT, Kuo HC: Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic Acid. PLoS One 2014;9:e91609. (SCI)
【11】Jhang JF, Hsu YH, Jiang YH, Kuo HC: Elevated serum IgE may be associated with development of ketamine cystitis. J Urol 2014;192:1249-56. (SCI)
【12】Jhang JF, Jiang YH, Kuo HC: Transurethral incision of the bladder neck improves voiding efficiency in female patients with detrusor underactivity. Int Urogynecol J 2014;25:671-6. (SCI)
【13】Jhang JF, Jiang YH, Kuo HC: Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis. Int J Urol 2014;21(Suppl 1):49-55. (SCI)
【14】Jiang YH, Liao CH, Tang DL, Kuo HC: Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder. PLoS One 2014;9:e105989. (SCI)
【15】Jiang YH, Kuo HC: Urothelial dysfunction and increased suburothelial inflammation of urinary bladder are involved in patients with upper urinary tract urolithiasis--clinical and immunohistochemistry study. PLoS One 2014;9:e110754. (SCI)
【16】Liu HT, Jiang YH, Kuo HC: Alteration of urothelial inflammation, apoptosis, and junction protein in patients with various bladder conditions and storage bladder symptoms suggest common pathway involved in underlying pathophysiology. Low Urin Tract Symptoms 2015;7:102-7. (SCI)
【17】Ke QS, Jiang YH, Kuo HC: Role of bladder neck and urethral sphincter dysfunction in men with persistent bothersome lower urinary tract symptoms after α-1 blocker treatment. Low Urin Tract Symptoms 2015;7:143-8. (SCI)
【18】Jiang YH, Ong HL, Kuo HC: Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxina injections for overactive bladder syndrome-A real-life practice of 290 cases in a single center. Neurourol Urodyn 2017;36:142-7.(SCI)
【19】Jiang YH, Liao CH, Kuo HC: Current and potential urological applications of botulinum toxin A. Nat Rev Urol 2015;12:519-33. (SCI)
【20】Jiang YH, Kuo HC: Reduction of urgency severity is the most important factor in the subjective therapeutic outcome of intravesical onabotulinumtoxinA injection for overactive bladder. Neurourol Urodyn 2017; 36:338-43. (SCI)
【21】Jiang YH, Liu HT, Kuo HC: Urothelial dysfunction and chronic inflammation in patients with spinal cord injuries at different levels and correlation with urodynamic findings. Neurourol Urodyn 2015;34:757-62. (SCI)
【22】Wu HT*, Jiang YH*, Liu AB, Liu CW, Ou YN, Kuo HC, Sun CK: Multiscale entropy analysis of surface electromyographic signals from urethral sphincter as a prognostic indicator for surgical candidates with primary bladder neck obstruction. Entropy 2015; 17:8089-98. (SCI) (*: equal contribution)
【23】Kuo HC, Jiang YH, Tsai YC, Kuo YC: Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn 2016;35:609-14 (SCI)
【24】Jhang JF, Jiang YH, Lee CL, Kuo HC: Long-term follow up and predictive factors for successful outcome of transurethral incision of the bladder neck in women with detrusor underactivity. J Formos Med Assoc 2016;115:807-13 (SCI)
【25】Jiang YH, Lee CL, Kuo HC: Urothelial dysfunction, suburothelial inflammation, and altered sensory protein expression in men with bladder outlet obstruction and various bladder dysfunctions: correlation with urodynamics. J Urol 2016;196:831-7 (SCI)
【26】Jiang YH, Jhang JF, Kuo HC: Revisiting the role of potassium sensitivity testing and cystoscopic hydrodistention for the diagnosis of interstitial cystitis. PLoS One 2016;11:e0151692. (SCI)
【27】Liao CH, Wang CC, Jiang YH: Intravesical onabotulinumtoxinA injection for overactive bladder patients with frailty, medical comorbidities or prior lower urinary tract surgery. Toxins (Basel). 2016;8(4):91. (SCI)
【28】Jhang JF, Hsu YH, Jiang YH, Kuo HC: The role of immunoglobulin E in the pathogenesis of ketamine related cystitis and ulcerative interstitial cystitis: An immunohistochemical study. Pain Physician 2016;19:E581-7. (SCI)
【29】Jiang YH, Wang CC, Kuo HC: OnabotulinumtoxinA urethral sphincter injection as treatment for non-neurogenic voiding dysfunction - A randomized, double-blind, placebo-controlled study. Sci Rep 2016;6:38905. (SCI)
【30】Wu SY, Jhang JF, Jiang YH, Kuo HC: Increased bladder wall thickness is associated with severe symptoms and reduced bladder capacity in patients with bladder pain syndrome. Urol Sci 2016;27:263-8.
【31】Jiang YH, Kuo HC: Urothelial barrier deficits, suburothelial inflammation and altered sensory protein expressions in detrusor underactivity. J Urol 2017; 197:197-203. (SCI)
【32】Wang CC, Jiang YH, Kuo HC: Efficacy and adherence of flexibly adding on a second antimuscarinic agent for patients with refractory overactive bladder. Low Urin Tract Symptoms 2017;9:27-32. (SCI)
【33】Jiang YH, Kuo HC: Reduction of urgency severity is the most important factor in the subjective therapeutic outcome of intravesical onabotulinumtoxinA injection for overactive bladder. Neurourol Urodyn 2017;36:338-43. (SCI)
【34】Jiang YH, Ong HL, Kuo HC: Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxinA injections for overactive bladder syndrome – a real-life practice of 290 cases in a single center. Neurourol Urodyn 2017;36:142-7.(SCI)
【35】Wu SY, Jiang YH, Kuo HC: Therapeutic efficacy of a new procedure for male incontinence combining a suburethral polypropylene mesh and cardiovascular patch. Int Neurourol J 2017;21:38-45. (SCI)
【36】Wu SY, Jiang YH, Kuo HC: Long-term outcome of augmentation enterocystoplasty in patients with end-stage bladder diseases: a single institute experience involving 102 patients. Int Neurourol J 2017;21:133-8. (SCI)
【37】Jiang YH, Kuo HC: Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men – a comparison of men with normal tracing and bladder outlet obstruction. PLoS One 2017;12:e0174593. (SCI)
【38】Jiang YH, Hong YL, Kuo HC: Urodynamic changes in patients with prostate cancer undergoing robotic-assisted radical prostatectomy: A comparison with laparoscopic radical prostatectomy. Urol Sci 2017;28:174-9.
【39】Jiang YH, Lee CL, Jhang JF, Kuo HC: Current pharmacological and surgical treatment of underactive bladder. Tzu Chi Med J 2017;29:187-91.
【40】Jiang YH, Liao CH, Kuo HC: Role of bladder dysfunction in men with lower urinary tract symptoms refractory to alpha-blocker therapy: a video-urodynamic analysis. Low Urin Tract Symptoms 2018; 10:32-7. (SCI)
【41】Jiang YH, Jhang JF, Chen SF, Kuo HC: Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity. Low Urin Tract Symptoms 2017; Oct 11. (SCI) [Epub ahead of print]
【42】Chen SF, Jiang YH, Kuo HC: Urinary biomarkers in patients with detrusor underactivity with and without bladder function recovery. Int Urol Nephrol 2017;49:1763-70. (SCI)
【43】Jiang YH, Jhang JF, Lee CL, Kuo HC. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxinA injection in the treatment of interstitial cystitis refractory to conventional treatment – A prospective, randomized, clinical trial. Neurourol Urodyn 2018;37:1467-73. (SCI)
【44】Jiang YH, Wang CC, Kuo HC: Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment. PLoS One 2018;13:e0190704.(SCI)
【45】Jhang JF, Hsu YH, Jiang YH, Lee CL, Kuo HC: Histopathological characteristics of ketamine-associated uropathy and their clinical association. Neurourol Urodyn 2018; 37:1764-72.(SCI)
【46】Chen SF, Jiang YH, Kuo HC: Urothelial dysfunction and chronic inflammation are associated with increased bladder sensation in patients with chronic renal insufficiency. Int Neurourol J 2018;22(Supp1 1):S46-54.(SCI)
【47】Chen SF, Jiang YH, Kuo HC: Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury. J Formosan Med Assoc 2018 Feb 23. [Epub ahead of print](SCI)
【48】Jhang JF, Hsu YH, Peng CW, Jiang YH, Ho HC, Kuo HC: Epstein–barr virus presence as a potential etiology of persistent bladder inflammation in human interstitial cystitis/bladder pain syndrome. J Urol 2018;200:590-6. (SCI)
【49】Jhang JF, Ho HC, Jiang YH, Lee CL, Hsu YH, Kuo HC: Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition. PLOS One 2018;13:e0198816. (SCI)
【50】Huang HC, Jiang YH, Lin Victor CH, Tsai YC, Kuo HC: Possible predictor of early recovery on urinary continence after laparoscopic radical prostatectomy – bladder neck level and urodynamic parameters. J Formosan Med Assoc 2018 Mar 24. [Epub ahead of print] (SCI)
【51】Jiang YH, Chen SF, Jhang JF, Kuo HC: Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity. Neurourol Urodyn 2018; 37:2651-7. (SCI)
【52】Chou YC, Jiang YH, Tomor Harnod, Lee HT, Shen CC, Kuo HC: Stroke and lower urinary tract symptoms. Urol Sci 2018 (Review) (Accepted-2018.09.11)
【53】Wu SY, Jiang YH, Kuo HC: Detrusor underactivity and bladder outlet procedures in men. Curr Bladder Dysfunct Rep 2018. (Review) (Online-2018.09.26)
【54】Wang CC, Jiang YH, Kuo HC: Higher urge severity score prediction of resumption of overactive bladder medication following discontinuation of mirabegron treatment in patients with overactive bladder. Low Urin Tract Symptoms 2018 (SCI)(Accepted-2018.11.27)